R3HDM1 and cancer: Notably, in most cancer types, heightened R3HDM1 levels exhibited a negative correlation with immune cell infiltration within tumors and antigen-presenting molecule expression, contrasting with a positive correlation observed with various immune negative regulatory molecules.